Cartalax Dosage Guide

Complete dosing protocol, reconstitution steps, and interactive calculator for Cartalax.

Dosing & Reconstitution Guide

Preclinical use of Cartalax has involved subcutaneous administration at 100–200 μg per day in short-term studies (7–10 days). No human dosing protocols are approved or validated.

Standard / Gradual Approach

20mg Vialstandard

PhaseDoseVolume

Weeks 1–22,000 mcg (2.0 mg)30 units (0.30 mL)

Weeks 3–43,000 mcg (3.0 mg)45 units (0.45 mL)

Weeks 5–84,000 mcg (4.0 mg)60 units (0.60 mL)

Weeks 9–125,000 mcg (5.0 mg)75 units (0.75 mL)

Protocol Summary

Subcutaneous (SQ): Daily · Dose range 2–6 mg with gradual titration

Cycle Length: 4–8 weeks typical; reassess before extending

Frequency & Cycling

SubQ

Inject 200 mcg daily for 10–20 days. Repeat every 3–6 months for chronic joint health maintenance. Split into 2–3 smaller daily doses if needed.

🧪 Quick Start

Vial Size

20 mg

BAC Water

3 mL

Concentration

6700 mcg/unit

Starting Dose

2,000 mcg (2.0 mg) (30 units (0.30 mL))

Maintenance Dose

5,000 mcg (5.0 mg) (75 units (0.75 mL))

🧮 Dose Calculator

Vial Size (mg)

BAC Water (mL)

Target Dose (mcg)

Concentration

66.7

mcg/unit

Draw Volume

units (0.070 mL)

For a 500 mcg dose, draw 7 units on a U-100 insulin syringe